ERBB2 and invasive breast carcinoma: Further, gene expression data from breast invasive carcinoma patients (TCGA data set) [36] revealed that PDCD4-AS1 showed lowest levels in basal-like or TNBC patients compared to Luminal A, Luminal B and HER2 subtypes (Fig 2F).